Market closed· · USD · Data may be delayed
Avg. target $23.89 (+12.2%)
Prices may be delayed and are for informational purposes only - not investment advice.
Calculated from the tables below and the current price ($21.30) · 2026/9 · Q3 · 2026-09-30
Latest quarter: flow lines (revenue, earnings, EPS, cash flow) are annualised (x4) and ignore seasonality. Book value and liabilities / equity come from the quarter-end balance sheet.
Fiscal year · $ billions · net margin below
| Fiscal year | Trend | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | 1,368 | 1,541+13% | 1,604+4% | |
| Cost of Revenue | ||||
| Gross Profit | ||||
| Operating expenses | ||||
| Operating Income | ||||
| EBITDA | ||||
| Pre-tax income | ||||
| Income tax (expense) / benefit | ||||
| Net Income | 256 | 244-5% | 309+27% | |
| Earnings per share ($) | ||||
| Margins | ||||
| Gross margin | ||||
| Operating margin | ||||
| EBITDA margin | ||||
| Net margin | ||||
Standardised statements compiled from the company's annual and interim reports. The "LTM" column covers the last four reported quarters; balance-sheet lines in it are from the latest quarter. Lines the company does not report are left blank rather than approximated. Not investment advice.